These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 14978349)

  • 1. Effects of 4-ethylamino-2-butynyl(2-cyclohexyl-2-phenyl)glycolate hydrochloride, a metabolite of oxybutynin, on bladder specimens and rhythmic bladder contraction in rats in comparison with oxybutynin.
    Uchida M; Koganei M; Murata N; Yamaji T
    J Pharmacol Sci; 2004 Feb; 94(2):122-8. PubMed ID: 14978349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of 4-ethylamino-2-butynyl(2-cyclohexyl-2-phenyl) glycolate, metabolite of oxybutynin, on intra-artery administered acetylcholine-induced urinary bladder contraction in anesthetized dogs].
    Uchida M; Nakajima M; Koganei M; Yamaji T
    Nihon Yakurigaku Zasshi; 2004 May; 123(5):363-71. PubMed ID: 15118260
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vivo demonstration of muscarinic receptor binding activity of N-desethyl-oxybutynin, active metabolite of oxybutynin.
    Oki T; Kawashima A; Uchida M; Yamada S
    Life Sci; 2005 Apr; 76(21):2445-56. PubMed ID: 15763076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the antimuscarinic and antispasmodic actions of racemic oxybutynin and desethyloxybutynin and their enantiomers with those of racemic terodiline.
    Smith ER; Wright SE; Aberg G; Fang Y; McCullough JR
    Arzneimittelforschung; 1998 Oct; 48(10):1012-8. PubMed ID: 9825119
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological effects of tolterodine on human isolated urinary bladder.
    Yono M; Yoshida M; Wada Y; Kikukawa H; Takahashi W; Inadome A; Seshita H; Ueda S
    Eur J Pharmacol; 1999 Mar; 368(2-3):223-30. PubMed ID: 10193658
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetics/pharmacodynamics analysis of the relationship between the in vivo micturition pressure and receptor occupancy of (R)-oxybutynin and its metabolite in rats.
    Mizushima H; Kinoshita K; Abe K; Ishizuka H; Yamada Y
    Biol Pharm Bull; 2007 May; 30(5):955-62. PubMed ID: 17473442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effects of propiverine hydrochloride (propiverine) on isolated rat and dog urinary bladder].
    Kaneko S; Nakano D; Ohara M; Nishimori T
    Nihon Yakurigaku Zasshi; 1999 Mar; 113(3):145-56. PubMed ID: 10347839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analogues of oxybutynin. Synthesis and antimuscarinic and bladder activity of some substituted 7-amino-1-hydroxy-5-heptyn-2-ones and related compounds.
    Carter JP; Noronha-Blob L; Audia VH; Dupont AC; McPherson DW; Natalie KJ; Rzeszotarski WJ; Spagnuolo CJ; Waid PP; Kaiser C
    J Med Chem; 1991 Oct; 34(10):3065-74. PubMed ID: 1920357
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effect of oxybutynin hydrochloride on isolated smooth muscles (ileum, urinary bladder and urethra)].
    Aida Y; Kaneko Y; Kasama T
    Nihon Yakurigaku Zasshi; 1986 Jun; 87(6):629-39. PubMed ID: 3744169
    [TBL] [Abstract][Full Text] [Related]  

  • 10. M(3) receptor antagonism by the novel antimuscarinic agent solifenacin in the urinary bladder and salivary gland.
    Ikeda K; Kobayashi S; Suzuki M; Miyata K; Takeuchi M; Yamada T; Honda K
    Naunyn Schmiedebergs Arch Pharmacol; 2002 Aug; 366(2):97-103. PubMed ID: 12122494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of L-arginine, mirabegron, and oxybutynin on the primary bladder afferent nerve activities synchronized with reflexic, rhythmic bladder contractions in the rat.
    Aizawa N; Homma Y; Igawa Y
    Neurourol Urodyn; 2015 Apr; 34(4):368-74. PubMed ID: 24532414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of mirabegron, a novel β3-adrenoceptor agonist, on primary bladder afferent activity and bladder microcontractions in rats compared with the effects of oxybutynin.
    Aizawa N; Homma Y; Igawa Y
    Eur Urol; 2012 Dec; 62(6):1165-73. PubMed ID: 22981677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological characterization of a new antimuscarinic agent, solifenacin succinate, in comparison with other antimuscarinic agents.
    Ohtake A; Saitoh C; Yuyama H; Ukai M; Okutsu H; Noguchi Y; Hatanaka T; Suzuki M; Sato S; Sasamata M; Miyata K
    Biol Pharm Bull; 2007 Jan; 30(1):54-8. PubMed ID: 17202659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Agents for the treatment of overactive detrusor. III. Synthesis and structure-activity relationships of N-(4-amino-2-butynyl)acetamide derivatives.
    Take K; Okumura K; Tsubaki K; Terai T; Shiokawa Y
    Chem Pharm Bull (Tokyo); 1992 Jun; 40(6):1415-23. PubMed ID: 1394662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological actions of AH-9700 on micturition reflex in anesthetized rats.
    Shimizu I; Kawashima K; Ishii D; Oku S; Kohayakawa H; Oka M
    Eur J Pharmacol; 2001 Jan; 412(2):171-9. PubMed ID: 11165228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological effects of imidafenacin (KRP-197/ONO-8025), a new bladder selective anti-cholinergic agent, in rats. Comparison of effects on urinary bladder capacity and contraction, salivary secretion and performance in the Morris water maze task.
    Kobayashi F; Yageta Y; Yamazaki T; Wakabayashi E; Inoue M; Segawa M; Matsuzawa S
    Arzneimittelforschung; 2007; 57(3):147-54. PubMed ID: 17469649
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effects of tiropramide hydrochloride on the isolated detrusor and intravesical pressure of the bladder in situ in rats].
    Uruno T; Murakami F; Wada K; Hizukuri M; Igarashi M; Yoshida K; Matsuoka Y; Sunagane N; Kubota K
    Nihon Yakurigaku Zasshi; 1992 Oct; 100(4):329-38. PubMed ID: 1446883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urodynamic effects of oxybutynin and tolterodine in conscious and anesthetized rats under different cystometrographic conditions.
    Angelico P; Velasco C; Guarneri L; Sironi G; Leonardi A; Testa R
    BMC Pharmacol; 2005 Oct; 5():14. PubMed ID: 16216132
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Urodynamic effects of intravesical oxybutynin chloride in conscious rats.
    Yokoyama O; Ishiura Y; Nakamura Y; Ohkawa M
    J Urol; 1996 Feb; 155(2):768-71. PubMed ID: 8558722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tolterodine--a new bladder-selective antimuscarinic agent.
    Nilvebrant L; Andersson KE; Gillberg PG; Stahl M; Sparf B
    Eur J Pharmacol; 1997 May; 327(2-3):195-207. PubMed ID: 9200560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.